1504 related articles for article (PubMed ID: 34719771)
1. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
2. Pathology of Neurodegenerative Diseases.
Dugger BN; Dickson DW
Cold Spring Harb Perspect Biol; 2017 Jul; 9(7):. PubMed ID: 28062563
[TBL] [Abstract][Full Text] [Related]
3. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.
Mueller SG; Schuff N; Weiner MW
NMR Biomed; 2006 Oct; 19(6):655-68. PubMed ID: 16986115
[TBL] [Abstract][Full Text] [Related]
5. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome assembly in neurodegenerative diseases.
Singh J; Habean ML; Panicker N
Trends Neurosci; 2023 Oct; 46(10):814-831. PubMed ID: 37633753
[TBL] [Abstract][Full Text] [Related]
7. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
[TBL] [Abstract][Full Text] [Related]
8. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
9. Lipids as Emerging Biomarkers in Neurodegenerative Diseases.
Wei J; Wong LC; Boland S
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203300
[TBL] [Abstract][Full Text] [Related]
10. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
11. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
12. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
Khaafi F; Javadi B
Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
[TBL] [Abstract][Full Text] [Related]
13. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.
Vucic S; Kiernan MC
Neurotherapeutics; 2017 Jan; 14(1):91-106. PubMed ID: 27830492
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW
J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747
[TBL] [Abstract][Full Text] [Related]
15. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
Yang J; Li H; Zhao Y
Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
[TBL] [Abstract][Full Text] [Related]
16. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
18. Effects of curcumin on mitochondria in neurodegenerative diseases.
Bagheri H; Ghasemi F; Barreto GE; Rafiee R; Sathyapalan T; Sahebkar A
Biofactors; 2020 Jan; 46(1):5-20. PubMed ID: 31580521
[TBL] [Abstract][Full Text] [Related]
19. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
[TBL] [Abstract][Full Text] [Related]
20. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
